Results 51 to 60 of about 1,439 (152)

To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?

, 2017
Background One of the major advantages of dalbavancin is that it may be administered as a single dose for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Nina Murphy, Dustin Freshwater, Michelle T Hecker   +2 more
core   +1 more source

Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). [PDF]

, 2020
Objectives We evaluated the efficacy and safety of dalbavancin in ABSSSI and 'other sites' infections' (OTA). Methods Observational study involving 11 Italian hospitals including patients that received >= 1 dose of dalbavancin in 2016-2019.
Moioli MC, Rizzi M, Cattelan A, Raumer F, Rizzi M., Saracino A, Raumer F., Borghi F, Aldieri C, Castelli F., Saracino A., Marchetti G., Di Meco E, d'Arminio Monforte A., Cascio A, Tordato F, Bai F, Menzaghi B., Migliorino G., Rizzardini G, Morelli P., Puoti M, Aldieri C., d'Arminio Monforte A, Van Hauwermeiren E., Cascio A., Tordato F., Moioli M. C., Puoti M., Di Meco E., Castelli F, Morelli P, Bai F., Cattelan A., Migliorino G, Van Hauwermeiren E, Menzaghi B, Borghi F., Rizzardini G.   +38 more
core   +1 more source

Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research

Angewandte Chemie International Edition, Volume 64, Issue 10, March 3, 2025.
This article provides an overview over antibacterial drugs investigated in the past three decades. Aspects of the compound's origins, their cellular targets, the antibacterial spectrum and proof‐of‐concept in animal studies are covered and current trends are highlighted.
Roderich D. Süssmuth, Marcel Kulike‐Koczula, Peng Gao, Simone Kosol   +3 more
wiley   +1 more source

Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments

Life, 2023
Oritavancin is a long-acting lipoglycopeptide with in vitro activity against Gram-positive pathogens, as well as good bactericidal activity and sterilisation ability in biofilm. It has been approved for acute bacterial skin and skin structure infections (
Tommaso Lupia, Ilaria De Benedetto, Roberta Bosio, Nour Shbaklo, Francesco Giuseppe De Rosa, Silvia Corcione   +5 more
doaj   +1 more source

NIR‐II emissive biohybrid nanovesicles as mild‐temperature photothermal antibiofilm agents against acute bacterial skin and skin‐structure infections

Interdisciplinary Medicine, Volume 3, Issue 1, January 2025.
A new NIR‐II emissive biohybrid nanovesicle (nano‐MBA) was designed as a mild‐temperature photothermal antibiofilm agent against acute bacterial skin and skin‐structure infections, enabling AIEgen‐based photothermal therapy and biofilm degradation treatment at a safe temperature (50°C).
Ji Wang, Zhihao Wu, Xiaoxi Ma, Zhihui Huang, Haorong Dong, Jinxin Zhang, Xiaoming Liu, Pengfei Zhang, Shuhuai Yao   +8 more
wiley   +1 more source

Dalbavancin to Complete a Prolonged Antibiotic Course for Persistent Bacillus cereus Bacteremia: A Case Report and Literature Review

Case Reports in Infectious Diseases, Volume 2025, Issue 1, 2025.
Bacillus cereus is a Gram‐positive, rod‐shaped facultative anaerobe commonly associated with gastrointestinal infections. Although typically regarded as a blood culture contaminant, B. cereus can cause severe infections, including bacteremia, in high‐risk patients.
Jahnavi Yetukuri, Joseph Choi, Andrew Darkow, Larry M. Bush   +3 more
wiley   +1 more source

Efficacy and safety of vancomycin compared with those of alternative treatments for methicillin‐resistant Staphylococcus aureus infections: An umbrella review

Journal of Evidence-Based Medicine, Volume 17, Issue 4, Page 729-739, December 2024.
Abstract Objective To summarize the evidence on the efficacy and safety of vancomycin compared with those of alternative treatments in adult patients with methicillin‐resistant Staphylococcus aureus (MRSA) infection. Methods PubMed, Embase, and Web of Science were searched up to December 15, 2023, for systematic reviews and meta‐analyses comparing ...
Sujata Purja, Minji Kim, Yomna Elghanam, Hae Jung Shim, Eunyoung Kim   +4 more
wiley   +1 more source

Dalbavancina long-acting per il trattamento delle infezioni batteriche acute di cute e strutture cutanee (ABSSSI): confronto con gli schemi terapeutici tradizionali

, 2019
Introduction Acute bacterial skin and skin structure infections (ABSSSI) have increased in incidence and severity. The involvement of resistant organisms, particularly methicillinresistant Staphylococcus aureus, presents additional challenges ...
Rosario Cultrera, Camilla Taglietti, Giulia Magnani, Francesco Turrini, Marco Libanore, Anna Marra, Brunella Quarta   +6 more
core   +1 more source

Factors Driving Emergency Department Revisits or Hospitalization Within 30 Days Post-Discharge in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

, 2015
ABSSSI is a major contributor to antibiotic use. While most patients (PTs) with ABSSSI present to the Emergency Department (ED) and are discharged on oral antibiotics, little is known about the frequency that patients with ABSSSI return to the ED or ...
Stenehjem, Edward, Brown, Jack, Goldwater, Shannon H., Zhu, Haiyuan, Owens, Robert, Scoble, Patrick, Zong, Yan   +6 more
core   +1 more source

Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience

Antibiotics
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are marked by substantial morbidity, frequent need for hospitalization, and long courses of intravenous antibiotic therapy. Herein, we report four cases of pediatric patients admitted for ABSSSI
Sara Maria Scarano, Eugenia Bruzzese, Marco Poeta, Margherita Del Bene, Alfredo Guarino, Andrea Lo Vecchio   +5 more
doaj   +1 more source